KAT5 and hepatocellular carcinoma: In our study, the data showed that the mRNA level of TWIST1 was upregulated in PCK1-deficient hepatoma cells, suggesting that PCK1 may transcriptionally inhibit TWIST1 by O-GlcNAcylation of KAT5.